Endeavour zotarolimus-eluting stent reduces stent thrombosis and improves clinical outcomes compared with cypher sirolimus-eluting stent: 4-year results of the PROTECT randomized trial-Reference-Cited by-同舟云学术

Endeavour zotarolimus-eluting stent reduces stent thrombosis and improves clinical outcomes compared with cypher sirolimus-eluting stent: 4-year results of the PROTECT randomized trial

Published:2014-08-08 Issue:40 Volume:35 Page:2812-2820
ISSN:0195-668X
Container-title:European Heart Journal
language:en
Short-container-title:European Heart Journal

Author:

Wijns W.,Steg P. G.,Mauri L.,Kurowski V.,Parikh K.,Gao R.,Bode C.,Greenwood J. P.,Lipsic E.,Alamgir F.,Rademaker-Havinga T.,Boersma E.,Radke P.,van Leeuwen F.,Camenzind E.,

Publisher

Oxford University Press (OUP)

Subject

Cardiology and Cardiovascular Medicine

Link

http://academic.oup.com/eurheartj/article-pdf/35/40/2812/17354813/ehu318.pdf

Reference25 articles.

1. Rationale and design of the Patient Related OuTcomes with Endeavor versus Cypher stenting Trial (PROTECT): Randomized controlled trial comparing the incidence of stent thrombosis and clinical events after sirolimus or zotarolimus drug-eluting stent implantation

2. Comparison of Zotarolimus-Eluting and Sirolimus-Eluting Stents in Patients With Native Coronary Artery Disease

3. Endothelial Cell Recovery Between Comparator Polymer-Based Drug-Eluting Stents

4. Stent thrombosis and major clinical events at 3 years after zotarolimus-eluting or sirolimus-eluting coronary stent implantation: a randomised, multicentre, open-label, controlled trial

5. Stent Thrombosis in Randomized Clinical Trials of Drug-Eluting Stents

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-World Implementation of a Genotype-Guided P2Y12 Inhibitor De-Escalation Strategy in Acute Coronary Syndrome Patients;JACC: Cardiovascular Interventions;2024-09

2. Revolutionizing Cardiovascular Frontiers: A Dive Into Cutting-Edge Innovations in Coronary Stent Technology;Cardiology in Review;2024-05-06

3. Individualization of Duration of Dual Antiplatelet Therapy after Coronary Stenting: A Comprehensive, Evidence-Based Review;Journal of Clinical Medicine;2023-11-17

4. The relation of polymer structure of stent used in patients with acute coronary syndrome revascularized by stent implantation with long‐term cardiovascular events;Catheterization and Cardiovascular Interventions;2023-10-19

5. Clinical Outcomes and Prognostic Factors in Complex, High-Risk Indicated Procedure (CHIP) and High-Bleeding-Risk (HBR) Patients Undergoing Percutaneous Coronary Intervention with Sirolimus-Eluting Stent Implantation: 4-Year Results;Journal of Clinical Medicine;2023-08-15